-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Initiates Coverage On Pelthos Therapeutics with Overweight Rating, Announces Price Target of $48

Benzinga·02/27/2026 10:56:28
Listen to the news
Piper Sandler analyst David Amsellem initiates coverage on Pelthos Therapeutics (AMEX:PTHS) with a Overweight rating and announces Price Target of $48.